Početna › Ulcerativni kolitis › Texas › Tyler
Kliničke studije za Ulcerativni kolitis u gradu Tyler, TX
14 studija za Ulcerativni kolitis traži sudionike na lokacijama u gradu Tyler i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
U tijeku regrutacijaFaza 3
- Tyler Research Institute ( Site 0294), Tyler
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
U tijeku regrutacijaFaza 2
- Tyler Research Institute, Tyler
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
U tijeku regrutacijaFaza 1/2Zdravi dobrovoljci dobrodošli
- Xencor Investigative Site, Tyler
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
U tijeku regrutacijaFaza 2
- Site US-004, Tyler
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
U tijeku regrutacijaFaza 3
- Tyler Research Institute, LLC, Tyler
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
U tijeku regrutacijaFaza 3
- Tyler Research Institute, Tyler
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
U tijeku regrutacijaFaza 2
- Tyler Research Institute, Tyler
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
U tijeku regrutacijaFaza 2
- Tyler Research Institute, Tyler
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
U tijeku regrutacijaFaza 4
- Tyler Research Institute, LLC, Tyler
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
U tijeku regrutacijaFaza 3
- Tyler Research Institute, LLC - Site Number: 8400095, Tyler
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
U tijeku regrutacijaFaza 3
- Tyler Research Institute, LLC, Tyler
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
U tijeku regrutacijaFaza 3
- Tyler Research Institute, LLC - Site Number: 8400095, Tyler
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
U tijeku regrutacijaFaza 2
- Tyler Research Institute, LLC, Tyler
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
U tijeku regrutacijaFaza 2
- Mirador Therapeutics Selected Site, Tyler
Studije za Ulcerativni kolitis u drugim gradovima
- New York City, NY23 studija
- Orlando, FL22 studija
- Miami, FL21 studija
- Houston, TX17 studija
- San Antonio, TX16 studija
- Chicago, IL15 studija
- Tacoma, WA15 studija
- San Diego, CA15 studija
- Colorado Springs, CO14 studija
- Los Angeles, CA13 studija
- St. Louis, MO13 studija
- Washington, DC12 studija
Ostale studije u gradu Tyler
- Nemikrocelularni karcinom pluća20 studija
- Crohnova bolest16 studija
- Kolorektalni rak8 studija
- Srčano zatajenje8 studija
- Rak (sve vrste)7 studija
- Rak jajnika7 studija
- Rak endometrija6 studija
- Pločastostanični karcinom glave i vrata6 studija
- Rak dojke6 studija
- Metastatski karcinom5 studija
- Upalna bolest crijeva5 studija
- Kronična limfocitna leukemija5 studija
Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.